December 01-03, 2020
Boston, USA
Pharmacovigilance will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of case studies and industry experiences. This conference will help the drug safety representatives from the pharmaceutical industry and academic and quality research organizations who wish to understand how to avoid common deficiencies in inspections by learning from the experiences of others, to gain a greater understanding of new and existing pv requirements, and to improve their organizations' compliance with pv requirements.